Akihiro Hirata
- Molecular Biology
- Oncology top 10%
- Genetics top 10%
- Pulmonary and Respiratory Medicine top 10%
- Surgery top 10%
- Co-authors
- Tokuma YanaiAkira HaraHiroyuki TomitaHiroki SakaiYuichiro HatanoH. SakaiPaul I. TerasakiGerhard Opelz
- Topics
- Veterinary Oncology Research (17 papers)Genetic factors in colorectal cancer (11 papers)Inflammatory Bowel Disease (11 papers)
- Journals
- The LancetSHILAP Revista de lepidopterologíaThe Journal of Immunology
- Partner nations
- JapanEgyptUnited States
In The Last Decade
Akihiro Hirata
139 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 115
- Molecular Biology 574
- Oncology 422
- Genetics 339
- Pulmonary and Respiratory Medicine 335
- Surgery 300
Countries citing papers authored by Akihiro Hirata
This map shows the geographic impact of Akihiro Hirata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Hirata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Hirata more than expected).
Fields of papers citing papers by Akihiro Hirata
This network shows the impact of papers produced by Akihiro Hirata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Hirata. The network helps show where Akihiro Hirata may publish in the future.
Co-authorship network of co-authors of Akihiro Hirata
This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Hirata. A scholar is included among the top collaborators of Akihiro Hirata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Hirata. Akihiro Hirata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 12 | |
| 9 | 23 | |
| 10 | 0 | |
| 11 | 3 | |
| 12 | 18 | |
| 13 | Assessment of Proliferative Activity by Proliferative Cell Nuclear Antigen (PCNA) and Anti-Bromodeoxyuridine (BrdU) Immunolabeling in the Tissues of Japanese Eels (Anguilla japonica) | 10 |
| 14 | 25 | |
| 15 | 21 | |
| 16 | 2 | |
| 17 | 14 | |
| 18 | 1 | |
| 19 | 5 | |
| 20 | 5 |
About Akihiro Hirata
Akihiro Hirata is a scholar working on Oncology, Small Animals and Biological Psychiatry, having authored 146 papers that have together received 1.8k indexed citations. Recurring topics across this work include Veterinary Oncology Research (17 papers), Genetic factors in colorectal cancer (11 papers) and Inflammatory Bowel Disease (11 papers). The work is most often cited by research in Biological Psychiatry (60 citations), Oncology (422 citations) and Cancer Research (191 citations). Akihiro Hirata has collaborated with scholars based in Japan, Egypt and United States. Frequent co-authors include Tokuma Yanai, Akira Hara, Hiroyuki Tomita, Hiroki Sakai, Yuichiro Hatano, H. Sakai, Paul I. Terasaki, Gerhard Opelz, Toshiaki Masegi and Motoi Uchino. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.